API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.fiercepharma.com/pharma/gsk-was-warned-repeatedly-about-zantac-risks-didnt-act-warnings-bloomberg
https://recalls-rappels.canada.ca/en/alert-recall/apo-acyclovir-tablets-ndma-impurity
https://www.europeanpharmaceuticalreview.com/news/172292/advancing-nitrosamines-analysis-with-gas-chromatography/
https://www.europeanpharmaceuticalreview.com/news/171874/majority-of-metformin-drugs-have-acceptable-nitrosamine-levels-finds-study/
https://www.newswire.ca/news-releases/advisory-apotex-recalls-apo-acyclovir-tablets-due-to-a-nitrosamine-impurity-831622325.html
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/viona-pharmaceuticals-inc-issues-voluntary-nationwide-recall-metformin-hcl-extended-release-tablets-0
https://www.pharmacompass.com/pdf/news/viona-pharma-issues-voluntary-nationwide-recall-of-metformin-hcl-er-tablets-for-ndma-impurity-1623740019.pdf
https://www.pharmacompass.com/pdf/news/health-canada-pharmascience-increcalls-of-pms-ranitidine-150mg-1612589331.pdf
https://www.tribuneindia.com/news/business/indian-drug-firms-recall-various-products-in-us-market-170632
https://www.pharmacompass.com/pdf/news/nostrum-laboratories-inc-issues-voluntary-nationwide-recall-of-metformin-hcl-extended-release-tablets-usp-750-mg-1604410216.pdf
https://www.pharmacompass.com/pdf/news/marksans-pharma-limited-issues-expansion-of-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-1601968692.pdf
https://www.slashgear.com/popular-diabetes-drug-recalled-months-after-fda-issued-cancer-risk-warning-27640043/
https://www.pharmacompass.com/pdf/news/sun-pharmaceutical-issues-recall-of-riometer-due-to-ndma-content-higher-than-adi-limit-1601355298.pdf
https://www.pharmacompass.com/pdf/news/sun-pharmaceutical-industries-inc-issues-voluntary-nationwide-recall-of-riomet-er-metformin-hydrochloride-for-extended-release-oral-suspension-1601968935.pdf
https://www.biospace.com/article/releases/sun-pharmaceutical-industries-inc-issues-voluntary-nationwide-recall-of-riomet-er-metformin-hydrochloride-for-extended-release-oral-suspension-due-to-n-nitrosodimethylamine-ndma-content-above-the-acceptable-daily-intake-adi-limit/
https://www.fda.gov/news-events/press-announcements/fda-provides-guidance-industry-detecting-and-preventing-nitrosamines-drugs
https://www.pharmacompass.com/pdf/news/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-1594396507.pdf
https://www.pharmacompass.com/pdf/news/granules-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-1594102684.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntarily-nationwide-recall-one-lot-metformin-hydrochloride
https://www.pharmacompass.com/pdf/news/marksans-pharma-limited-issues-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-1591423317.pdf
https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticals-bridgewater-new-jersey-amneal-is-voluntarily-recalling-all-lots-of-metformin-hydrochloride-extended-release-tablets-usp-500-mg-and-750-mg-within-expiry-to-the-retail-level-1591090849.pdf
https://www.thehindu.com/news/international/usfda-for-recall-of-diabetes-drug-metformin-after-tests-find-high-levels-of-carcinogen/article31707744.ece
https://www.pharmacompass.com/pdf/news/apotex-corp-issues-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-500mg-due-to-the-detection-of-n-nitrosodimethylamine-ndma-1590747013.pdf
https://www.ndtv.com/world-news/us-food-and-drug-administration-asks-5-firms-to-recall-diabetes-drug-metformin-over-carcinogen-concerns-2236974
https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticals-issues-voluntary-nationwide-recall-of-nizatidine-oral-solution-1587013187.pdf
https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticalsissues-voluntary-nationwide-recall-of-nizatidine-oral-solution-1587446824.pdf
https://www.business-standard.com/article/companies/aurobindo-pharma-faces-class-action-suit-in-us-for-concealing-facts-120040701355_1.html
https://www.pharmacompass.com/pdf/news/american-health-packaging-issues-voluntary-nationwide-recall-of-ranitidine-tablets-1582867140.pdf
https://markets.businessinsider.com/news/stocks/information-update-certain-metformin-diabetes-drugs-recalled-due-to-the-presence-of-ndma-1028942508
https://www.raps.org/news-and-articles/news-articles/2020/2/ndma-in-metformin-fda-finds-low-levels-in-only-2
https://www.fiercepharma.com/manufacturing/more-generic-zantac-recalled-as-ndma-contamination-concerns-build
https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html
https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html
https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html
https://www.fiercepharma.com/manufacturing/after-zantac-scare-regulators-turn-to-generic-metformin-for-carcinogen-tests
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-4-2019-1575442774.pdf
https://www.hsa.gov.sg/announcements/news/hsa-recalls-three-out-of-46-metformin-medicines
https://www.business-standard.com/article/news-cm/solara-active-pharma-sciences-update-on-ranitidine-hydrochloride-nizatidine-api-119110400595_1.html
https://www.raps.org/news-and-articles/news-articles/2019/11/contamination-potential-leads-uk-to-fifth-recall-o
https://www.pharmacompass.com/pdf/news/golden-state-medical-supply-issues-a-voluntary-nationwide-recall-of-ranitidine-hydrochloride-1574235383.pdf
https://www.pharmacompass.com/pdf/news/precision-dose-inc-issues-voluntary-nationwide-recall-of-ranitidine-oral-solution-1574235567.pdf
https://www.fiercepharma.com/manufacturing/mylan-plant-knocked-for-inadequate-manufacturing-controls-tainted-valsartan-fiasco
https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticals-issues-voluntary-nationwide-recall-of-ranitidine-tablets-1573624886.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-relaunches-ranitidine-tablets-in-us/articleshow/71968842.cms
https://www.washingtonpost.com/science/a-tiny-pharmacy-is-identifying-big-problems-with-common-drugs-including-zantac/2019/11/08/6dd009ca-eb76-11e9-9c6d-436a0df4f31d_story.html
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aurobindo-pharma-usa-inc-initiates-voluntary-nationwide-consumer-level-recall-38-lots-ranitidine